Israel Evacuates Surrogate Babies From Nepal but Leaves the Mothers Behind
By Debra Kamin,
Time
| 04. 28. 2015
Untitled Document
An Israeli Boeing-747 returned from Nepal to Israel’s Ben Gurion International Airport on Tuesday afternoon, and among its 229 passengers were 15 Israeli babies, all born within the past six weeks to surrogate mothers in Nepal.
Some of the babies were with their Israeli parents and others were cared for by Israeli passengers. None of the surrogate mothers were allowed to travel.
The infants’ arrival completed the evacuation of 26 surrogate Israeli babies from Nepal, where a devastating earthquake on Saturday killed more than 4,000. The rescue process, coupled with widely published photos of the newborns being cradled by Israeli medics on the Tel Aviv tarmac, has thrust Israel’s reliance on Nepalese surrogates into the spotlight, revealing a little known link between Nepal and Israel and starting a debate here about the ethics of international surrogacy.
Only heterosexual couples can easily employ surrogate mothers in Israel. Gay couples and single parents tend to look abroad to bear children with surrogates. For many years, India — where costs are low but the standard of medical care is generally high...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...